News
March 2004 Affymetrix Showcases Third-Party Microarray Analysis Software Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research ...
Genomatix Software GmbH today announced that it has achieved GeneChip-compatibleTM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it ...
Affymetrix to launch Affymetrix University, a series of hands-on data analysis training courses that will be held in various locations throughout Europe and North America.
Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...
After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome.
RNA degradation per se does not preclude microarray analysis with Affymetrix platforms (Schoor et al, 2003; Lee et al, 2005b), which by design are ideally suited to interrogate RNA fragments.
This robust RNA amplification and labeling solution combined with a range of 3' IVT microarrays offered from Affymetrix – Almac Xcel™ Array, GeneChipHuman Genome U133 Plus 2.0 Array, and ...
With the Affymetrix arrays and DNA analysis instrumentation, Epigenomics can now provide a complete platform for its pathology tests based on DNA methylation methods, according to the company.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results